Skip to content

SCHEDULE 13D/AAccepted Apr 1, 4:10 PM ET

Neumora Therapeutics, Inc. SCHEDULE 13D/A

ARCH Venture Fund XII, L.P.

Accepted (ET)

4:10 PM

Apr 1, 2026

Filed

Apr 1, 2026

Documents

1

Size

35.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.